Search
for
Sort by
Research 421–450 of 1000+
- Vibration assisted analgesia during intralesional corticosteroid therapy for alopecia
- BH07 The socioeconomic burden of alopecia areata
- Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review
- Drug-Induced Hair Changes
- Infliximab-Associated Psoriasiform Alopecia
- 76532 Estetrol (E4) prolongs anagen in healthy and female pattern hair loss hair follicles ex vivo
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Segmental heterochromia with calibre change: a rare sign of alopecia areata
- BH14 Fibrosing alopecia in a patterned distribution following photodynamic therapy for actinic keratosis: a potential trigger for scarring alopecia
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM ‐1 Upregulation
- 030 Impaired Glutathione Synthesis in Hair Follicle Stem Cell Niches in Alopecia Areata
- 354 Investigating early molecular changes in a model of x-ray radiation-induced alopecia: spotlight on growth arrest and endothelial dysfunction
- 459 Estetrol prevents catagen progression in healthy and female pattern hair loss hair follicles ex vivo
- A multicentre cohort study of the clinicopathological features and treatment outcomes of fibrosing alopecia in a pattern distribution
- 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries
- The emotional impact of alopecia and role of psychological interventions in supporting patients with hair loss
- Quality Analysis of Shampoo Based on Rosemary Essential Oil (Rosmarinus officinalis L.) Concentration
- P079 Treatment and referral pathways for hair loss in the National Health Service: a patient survey
- BH21 Segmented heterochromia with calibre change: an under-recognized sign of alopecia areata
- BH11 Desperate for answers: the need for information at the onset of hair loss
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- BI39 Oncological therapies and hair disorders: a narrative approach on permanent chemotherapy-induced alopecia. A literature review of cancer-related therapies and their associated hair and scalp disorders
- BH13 Current wig prescribing practices and financial evaluation in a National Health Service foundation trust: lessons learnt and future challenges
- BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists
- BH02 (P100) Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice
- P100 Critically appraised topic: is dupilumab a cause or a treatment for alopecia areata? A case series and literature review to guide discussions in clinical practice